| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 379.20B | 375.85B | 362.20B | 373.83B | 354.08B | 336.40B |
| Gross Profit | 73.01B | 70.95B | 67.14B | 75.40B | 76.22B | 64.63B |
| EBITDA | 19.77B | 20.37B | 17.32B | 28.80B | 31.48B | 21.90B |
| Net Income | 13.13B | 11.33B | 10.10B | 15.77B | 21.49B | 10.02B |
Balance Sheet | ||||||
| Total Assets | 205.58B | 207.98B | 199.45B | 193.84B | 218.46B | 175.88B |
| Cash, Cash Equivalents and Short-Term Investments | 72.63B | 73.50B | 64.85B | 51.18B | 64.83B | 49.91B |
| Total Debt | 14.48B | 17.50B | 19.60B | 16.97B | 28.94B | 19.97B |
| Total Liabilities | 79.78B | 78.91B | 81.38B | 81.46B | 97.57B | 83.36B |
| Stockholders Equity | 115.60B | 118.65B | 108.39B | 103.49B | 112.95B | 85.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.58B | 15.02B | 19.43B | 11.77B | 11.05B |
| Operating Cash Flow | 0.00 | 17.31B | 18.25B | 24.25B | 15.77B | 15.71B |
| Investing Cash Flow | 0.00 | -3.67B | -600.00M | -7.81B | -6.22B | -8.40B |
| Financing Cash Flow | 0.00 | -6.03B | -3.75B | -31.89B | 4.22B | 6.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥85.96B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
75 Outperform | ¥148.39B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
66 Neutral | ¥166.58B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥31.12B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥98.36B | 15.20 | 2.57% | 1.97% | 19.61% | ― |